Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:40 PM
Study NCT ID:
NCT04419467
Status:
COMPLETED
Last Update Posted:
2023-12-06
First Post:
2020-06-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease
Sponsor:
CSL Behring
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-24
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-03
First Submit QC Date:
None
Study First Post Date:
2020-06-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-10-24
Results First Submit QC Date:
None
Results First Post Date:
2023-12-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-05
Last Update Post Date:
2023-12-06
Last Update Post Date Type:
ACTUAL